Bradykinin Potentiator B; Angiotensin I Converting Enzyme Inhibi

Angiotensin Converting Enzyme Inhibitor (ACE inhibitor), secreted by the Bothrops venom gland, inhibits the activity of the angiotensin-converting enzyme (ACE) and enhances the action of bradykinin by inhibiting the peptidases that inactivate it.

Bradykinin Potentiator B; Angiotensin I Converting Enzyme Inhibi is a synthetic research peptide in the angiotensin peptide family. The renin-angiotensin system generates bioactive peptides by sequential proteolysis. Angiotensin I is converted by ACE to angiotensin II, while shorter metabolites such as angiotensin III and angiotensin IV have distinct receptor and enzymatic contexts. Exact residue numbering is therefore essential.

• ACE substrate and inhibition studies
• angiotensin receptor assays
• renin-angiotensin processing studies
• fragment structure-activity comparisons

The exact sequence, residue range, species, terminal state, and chemical modifications should be matched to the intended assay. Fragmentation or processing can materially alter receptor selectivity, potency, aggregation, or enzymatic behavior.

1. Angiotensin peptide processing literature